Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian K Law

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Cells|January 21, 2023
Who Knew? Dopamine Transporter Activity Is Critical in Innate and Adaptive Immune ResponsesAdithya Gopinath, Phillip M Mackie, Leah T Phan, et al.
Protein Expression and Purification|September 10, 2003
Parallel purification of three catalytic subunits of the protein serine/threonine phosphatase 2A family (PP2A(C), PP4(C), and PP6(C)) and analysis of the interaction of PP2A(C) with alpha4 proteinSusanne Kloeker, Robin Reed, Jamie L McConnell, et al.
The Journal of Clinical Investigation|October 11, 2016
Epithelial-to-mesenchymal transition confers pericyte properties on cancer cellsAnitha K Shenoy, Yue Jin, Huacheng Luo, et al.
Oncotarget|September 17, 2017
NSC30049 inhibits Chk1 pathway in 5-FU-resistant CRC bulk and stem cell populationsSatya Narayan, Aruna S Jaiswal, Ritika Sharma, et al.
Chemmedchem|May 1, 2022
Anticancer Agents Derived from Cyclic Thiosulfonates: Structure-Reactivity and Structure-Activity RelationshipsAmanda F Ghilardi, Elham Yaaghubi, Renan B Ferreira, et al.
Frontiers in Pharmacology|January 31, 2022
Repurposing Tranexamic Acid as an Anticancer AgentMary E Law, Bradley J Davis, Amanda F Ghilardi, et al.
Cancer Letters|December 1, 2012
Development of an anti-angiogenic therapeutic model combining scAAV2-delivered siRNAs and noninvasive photoacoustic imaging of tumor vasculature developmentQing Ruan, Lei Xi, Sanford L Boye, et al.
Cells|July 27, 2022
Epithelial-Mesenchymal Transition Suppresses AMPK and Sensitizes Cancer Cells to Pyroptosis under Energy StressMingwei Liang, Jennifer W Li, Huacheng Luo, et al.
Cell Death Discovery|December 17, 2019
Disulfide bond-disrupting agents activate the tumor necrosis family-related apoptosis-inducing ligand/death receptor 5 pathwayMengxiong Wang, Mary E Law, Bradley J Davis, et al.
Oncotarget|April 21, 2017
Disulfide bond disrupting agents activate the unfolded protein response in EGFR- and HER2-positive breast tumor cellsRenan B Ferreira, Mengxiong Wang, Mary E Law, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Cells|January 21, 2023
Who Knew? Dopamine Transporter Activity Is Critical in Innate and Adaptive Immune ResponsesAdithya Gopinath, Phillip M Mackie, Leah T Phan, et al.
Protein Expression and Purification|September 10, 2003
Parallel purification of three catalytic subunits of the protein serine/threonine phosphatase 2A family (PP2A(C), PP4(C), and PP6(C)) and analysis of the interaction of PP2A(C) with alpha4 proteinSusanne Kloeker, Robin Reed, Jamie L McConnell, et al.
The Journal of Clinical Investigation|October 11, 2016
Epithelial-to-mesenchymal transition confers pericyte properties on cancer cellsAnitha K Shenoy, Yue Jin, Huacheng Luo, et al.
Oncotarget|September 17, 2017
NSC30049 inhibits Chk1 pathway in 5-FU-resistant CRC bulk and stem cell populationsSatya Narayan, Aruna S Jaiswal, Ritika Sharma, et al.
Chemmedchem|May 1, 2022
Anticancer Agents Derived from Cyclic Thiosulfonates: Structure-Reactivity and Structure-Activity RelationshipsAmanda F Ghilardi, Elham Yaaghubi, Renan B Ferreira, et al.
Frontiers in Pharmacology|January 31, 2022
Repurposing Tranexamic Acid as an Anticancer AgentMary E Law, Bradley J Davis, Amanda F Ghilardi, et al.
Cancer Letters|December 1, 2012
Development of an anti-angiogenic therapeutic model combining scAAV2-delivered siRNAs and noninvasive photoacoustic imaging of tumor vasculature developmentQing Ruan, Lei Xi, Sanford L Boye, et al.
Cells|July 27, 2022
Epithelial-Mesenchymal Transition Suppresses AMPK and Sensitizes Cancer Cells to Pyroptosis under Energy StressMingwei Liang, Jennifer W Li, Huacheng Luo, et al.
Cell Death Discovery|December 17, 2019
Disulfide bond-disrupting agents activate the tumor necrosis family-related apoptosis-inducing ligand/death receptor 5 pathwayMengxiong Wang, Mary E Law, Bradley J Davis, et al.
Oncotarget|April 21, 2017
Disulfide bond disrupting agents activate the unfolded protein response in EGFR- and HER2-positive breast tumor cellsRenan B Ferreira, Mengxiong Wang, Mary E Law, et al.
Pageof 7